Johnson & Johnson
JNJ
3,625 hedge funds and large institutions have $296B invested in Johnson & Johnson in 2022 Q3 according to their latest regulatory filings, with 115 funds opening new positions, 1,693 increasing their positions, 1,443 reducing their positions, and 117 closing their positions.
33% more call options, than puts
Call options by funds: $3.67B | Put options by funds: $2.75B
17% more repeat investments, than reductions
Existing positions increased: 1,693 | Existing positions reduced: 1,443
0.28% less ownership
Funds ownership: 69.11% → 68.84% (-0.28%)
2% less first-time investments, than exits
New positions opened: 115 | Existing positions closed: 117
1% less funds holding
Funds holding: 3,674 → 3,625 (-49)
5% less funds holding in top 10
Funds holding in top 10: 772 → 730 (-42)
8% less capital invested
Capital invested by funds: $323B → $296B (-$27B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
+$572M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$476M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$404M |
| 4 |
Barclays
London,
United Kingdom
|
+$349M |
| 5 |
D.E. Shaw & Co
New York
|
+$180M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$933M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$916M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$518M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$298M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$261M |
JNJ Hedge Fund Activity: Q3 2022 in Review
3,625 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2022, worth a combined $296B — down 8.4% from $323B a quarter earlier.
Sellers outnumbered buyers: 117 funds closed out of JNJ and 115 opened new positions — a net loss of 2 holders — while 1,443 trimmed existing stakes and 1,693 added.
The largest buyer was Amundi, adding an estimated $572M. The largest seller was BlackRock, cutting an estimated $933M.
- 3,625 institutional investors held Johnson & Johnson (JNJ) as of Q3 2022, down from 3,674 in Q2 2022.
- Funds reported $296B of Johnson & Johnson stock for Q3 2022, down 8.4% quarter-over-quarter.
- 115 funds opened new Johnson & Johnson positions in Q3 2022 and 117 closed out, a net change of -2 holders.
- The largest Johnson & Johnson buyer in Q3 2022 was Amundi, an estimated $572M added.
- The largest Johnson & Johnson seller in Q3 2022 was BlackRock, an estimated $933M sold.
Based on aggregated 13F filings for Q3 2022.